nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide
|
Kotsakis, Athanasios |
|
2014 |
86 |
1 |
p. 59-66 8 p. |
artikel |
2 |
Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study
|
Santoro, Armando |
|
2014 |
86 |
1 |
p. 47-53 7 p. |
artikel |
3 |
Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
|
Pallaud, Celine |
|
2014 |
86 |
1 |
p. 67-72 6 p. |
artikel |
4 |
Contents
|
|
|
2014 |
86 |
1 |
p. v-vi nvt p. |
artikel |
5 |
Editorial Board
|
|
|
2014 |
86 |
1 |
p. iii- 1 p. |
artikel |
6 |
Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)
|
Sarosi, Veronika |
|
2014 |
86 |
1 |
p. 54-58 5 p. |
artikel |
7 |
Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
|
Robinson, Cleo |
|
2014 |
86 |
1 |
p. 29-34 6 p. |
artikel |
8 |
Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: Adjusting quality-of-life and lead-time bias for utility of surgery
|
Yang, Szu-Chun |
|
2014 |
86 |
1 |
p. 96-101 6 p. |
artikel |
9 |
High exposure to erlotinib and severe drug-induced interstitial lung disease in patients with non-small-cell lung cancer
|
Fujita, Ken-ichi |
|
2014 |
86 |
1 |
p. 113-114 2 p. |
artikel |
10 |
Identification of actionable mutations in malignant pleural mesothelioma
|
Shukuya, Takehito |
|
2014 |
86 |
1 |
p. 35-40 6 p. |
artikel |
11 |
Interval lung cancers not detected on screening chest X-rays: How are they different?
|
Kvale, Paul A. |
|
2014 |
86 |
1 |
p. 41-46 6 p. |
artikel |
12 |
Is 18F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis
|
Treglia, Giorgio |
|
2014 |
86 |
1 |
p. 5-13 9 p. |
artikel |
13 |
Lung cancer in the era of Greek economic crisis
|
Saloustros, Emmanouil |
|
2014 |
86 |
1 |
p. 112-113 2 p. |
artikel |
14 |
Metastatic sites and survival in lung cancer
|
Riihimäki, M. |
|
2014 |
86 |
1 |
p. 78-84 7 p. |
artikel |
15 |
Optimal mediastinal staging in non-small cell lung cancer: What is the role of TEMLA and VAMLA?
|
Kużdżał, Jarosław |
|
2014 |
86 |
1 |
p. 1-4 4 p. |
artikel |
16 |
Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009
|
Houston, Keisha A. |
|
2014 |
86 |
1 |
p. 22-28 7 p. |
artikel |
17 |
Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature
|
Bruixola, Gema |
|
2014 |
86 |
1 |
p. 105-111 7 p. |
artikel |
18 |
Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan
|
Tiseo, Marcello |
|
2014 |
86 |
1 |
p. 91-95 5 p. |
artikel |
19 |
Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy
|
Mellema, Wouter W. |
|
2014 |
86 |
1 |
p. 73-77 5 p. |
artikel |
20 |
Successful empirical erlotinib treatment of a mechanically ventilated patient newly diagnosed with metastatic lung adenocarcinoma
|
Bosch-Barrera, Joaquim |
|
2014 |
86 |
1 |
p. 102-104 3 p. |
artikel |
21 |
Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients
|
Schabath, Matthew B. |
|
2014 |
86 |
1 |
p. 14-21 8 p. |
artikel |
22 |
Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer
|
Yoo, Seung Soo |
|
2014 |
86 |
1 |
p. 85-90 6 p. |
artikel |